Cargando…

A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis

The mechanisms that promote local inflammatory injury during lupus nephritis (LN) flare are largely unknown. Understanding the key immune cells that drive intrarenal inflammation will advance our knowledge of disease pathogenesis and inform the development of new therapeutics for LN management. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parikh, Samir V., Malvar, Ana, Shapiro, John, Turman, James M., Song, Huijuan, Alberton, Valeria, Lococo, Bruno, Mejia-Vilet, Juan M., Madhavan, Sethu, Zhang, Jianying, Yu, Lianbo, Satoskar, Anjali A., Birmingham, Dan, Jarjour, Wael N., Rovin, Brad H., Ganesan, Latha P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919935/ https://www.ncbi.nlm.nih.gov/pubmed/33659005 http://dx.doi.org/10.3389/fimmu.2021.621039

Ejemplares similares

Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders
por: Parikh, Samir V, et al.
Publicado: (2015)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
por: Ayoub, Isabelle, et al.
Publicado: (2020)

Rethinking Lupus Nephritis Classification on a Molecular Level
por: Almaani, Salem, et al.
Publicado: (2019)

Remission of lupus nephritis: the trajectory of histological response in successfully treated patients
por: Malvar, Ana, et al.
Publicado: (2023)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Anti−PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1
por: Cassol, Clarissa, et al.
Publicado: (2019)

Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
por: Budu-Grajdeanu, Paula, et al.
Publicado: (2010)

The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
por: Mejía-Vilet, Juan M., et al.
Publicado: (2021)

Limited Reliability of the Spot Urine Protein/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis
por: Shidham, Ganesh, et al.
Publicado: (2018)

The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its Flare
por: Toy, Chris R., et al.
Publicado: (2021)

Membranous Nephropathy With Crescents
por: Alawieh, Rasha, et al.
Publicado: (2020)

Can Antinuclear Antibodies (ANA) be Monoclonal?
por: Biederman, Laura, et al.
Publicado: (2021)

Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy
por: Dasgupta, Alana, et al.
Publicado: (2023)

Renal flare as a biomarker of incident and progressive chronic kidney disease in patients with lupus nephritis
por: Parikh, S, et al.
Publicado: (2012)

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021)

Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19
por: Calomeni, Edward, et al.
Publicado: (2020)

Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicine
por: Anders, Hans-Joachim, et al.
Publicado: (2015)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases
por: Brodsky, Sergey V., et al.
Publicado: (2019)

Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study
por: Satoskar, Anjali A., et al.
Publicado: (2020)

Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
por: Satoskar, Anjali A., et al.
Publicado: (2022)

Anticoagulant Related Nephropathy Only Partially Develops in C57BL/6 Mice: Hematuria Is Not Accompanied by Red Blood Cell Casts in the Kidney
por: Medipally, Ajay K., et al.
Publicado: (2021)

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
por: Furie, Richard A, et al.
Publicado: (2022)

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
por: Zavala-Miranda, María Fernanda, et al.
Publicado: (2021)

Role of glomerular filtration rate‐modifying drugs in the development of anticoagulant‐related nephropathy
por: Medipally, Ajay K., et al.
Publicado: (2021)

Chronic Hematuria Increases Chronic Kidney Injury and Epithelial–Mesenchymal Transition in 5/6 Nephrectomy Rats
por: Xiao, Min, et al.
Publicado: (2021)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis
por: De Rosa, Marcelo, et al.
Publicado: (2020)

Gut dysbiosis is associated with acceleration of lupus nephritis
por: Valiente, Giancarlo R., et al.
Publicado: (2022)

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
por: Tamirou, Farah, et al.
Publicado: (2015)

N‐acetylcysteine ameliorates hematuria‐associated tubulointerstitial injury in 5/6 nephrectomy mice
por: Medipally, Ajay, et al.
Publicado: (2023)

Characterization of Glomerular Diseases Using Proteomic Analysis of Laser Capture Microdissected Glomeruli
por: Satoskar, AA, et al.
Publicado: (2012)

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis
por: Gomez Mendez, Liliana Michelle, et al.
Publicado: (2019)

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
por: Almaani, Salem, et al.
Publicado: (2020)

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
por: Azzouz, Doua, et al.
Publicado: (2019)

The Contiguity Processor for DELPHI
por: DELPHI Collaboration
Publicado: (1983)

Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
por: Jayne, David, et al.
Publicado: (2023)

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
por: Schwartz, Noa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_44a3kdl4fbg17dnijfbq0ch011